Home / Business and Economy / QuidelOrtho Eyes $1.5B Sale of Testing Unit
QuidelOrtho Eyes $1.5B Sale of Testing Unit
27 Jun
Summary
- QuidelOrtho Corp is exploring a sale of its point-of-care testing unit.
- The diagnostics firm seeks a valuation of approximately $1.5 billion for the unit.
- Several private equity firms have reportedly shown interest in the acquisition.
Diagnostics firm QuidelOrtho Corp is reportedly seeking to divest its point-of-care testing unit. The company aims for a valuation of approximately $1.5 billion for this business. The Financial Times has indicated that this potential sale has attracted attention from several prominent private equity firms.
Firms such as Advent International, SK Capital Partners, and Archimed have allegedly expressed interest in acquiring the diagnostics asset. This move by QuidelOrtho suggests a strategic realignment within the rapidly evolving healthcare diagnostics sector.
Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
